Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II of Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

NCT00353717 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00353717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00353717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II of Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2006
Completion date
September 30, 2009
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms